A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...

Flow is a transcranial direct current stimulation device that delivers low-intensity direct electrical current to specific areas of the brain through electrodes that are placed on the scalp.

The FDA on Thursday approved a transcranial direct current stimulation (tDCS) device as the first at-home non-drug therapy for major depression in adults, maker Flow Neuroscience announced.

The FDA recently cleared this device for sale in the U.S. Research shows it can improve moderate to severe depression ...

A small study shows cognitive improvements in patients with AD following treatment with an in-home gamma sensory stimulation ...

Patients can use the headset themselves in their homes to counteract moderate to severe depression, with what the FDA says are “modest” results.

The FDA has approved Flow, a prescription home-use cranial electrotherapy stimulation device, for treating moderate to severe ...